Patents by Inventor Patrick Vaughan

Patrick Vaughan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060094009
    Abstract: A method for characterising nucleic acid molecules comprises the steps of i) introducing a modified base which is a substrate for a DNA endonuclease, for example Endonuclease V from E. coli, into a target DNA molecule; and ii) reacting the nucleic acid containing the modified base with said DNA endonuclease such that the nucleic acid is cleaved to generate an upstream fragment condition said modified base and bearing a 3? hydroxyl group. The upstream fragment generated in step ii) can be used as a primer for a subsequent extension reaction. The modified base as such targets cleavage of the nucleic acid strand because it directs the endonuclease to cut the nucleic acid strand on which it resides at a site predominantly one nucleotide removed therefrom, so that the modified base remains in the nucleci acid as th upstream fragment. The method can be used for detecting polymorphisms and mutations and for nucleic acid indentification and profiling.
    Type: Application
    Filed: June 25, 2003
    Publication date: May 4, 2006
    Inventors: Patrick Vaughan, Thomas McCarthy
  • Patent number: D327857
    Type: Grant
    Filed: June 21, 1990
    Date of Patent: July 14, 1992
    Inventor: Patrick Vaughan
  • Patent number: D1090825
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: August 26, 2025
    Assignee: ABIOMED, INC.
    Inventors: Cam Loughlin, Zhenghong Tao, Jairo Moux, Patrick Vaughan